IP Verse

Compositions And Methods For Lowering Triglycerides Without Raising Ldl-C Levels In A Subject On Concomitant Statin Therapy

Patent No. EP3318255 (titled "Compositions And Methods For Lowering Triglycerides Without Raising Ldl-C Levels In A Subject On Concomitant Statin Therapy") was filed by Amarin Pharmaceuticals Ireland on Jun 15, 2010. The application was issued on Mar 10, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
COOKEDec 10, 2021ELKINGTON AND FIFE
HOFFMANN EITLEDec 8, 2021HOFFMANN EITLE
ELKINGTON AND FIFENov 24, 2021ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3318255

AMARIN PHARMACEUTICALS IRELAND
Application Number
EP17187534A
Filing Date
Jun 15, 2010
Status
Revoked
Oct 21, 2022
Publication Date
Mar 10, 2021
External Links
Slate, Register , Google Patents